skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines dacomitinib monohydrateQuestion & answer

dacomitinib monohydrate · Medicine question

What is the plasma half-life of dacomitinib (Vizimpro)?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The plasma half-life of dacomitinib (Vizimpro) ranges from 54 to 80 hours.

Sources for this answer

Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated 5 November 2024

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

dacomitinib monohydrate

More questions about dacomitinib monohydrate

Have fertility studies been performed with dacomitinib monohydrate (Vizimpro)?How common was stomatitis (mouth inflammation or sores) in patients receiving dacomitinib monohydrate (Vizimpro) in the pooled clinical safety data?How does dacomitinib monohydrate (Vizimpro) affect exposure to dextromethorphan?How long is contraception recommended after completing dacomitinib monohydrate (Vizimpro) treatment?Is breastfeeding recommended during treatment with dacomitinib monohydrate (Vizimpro)?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the dacomitinib monohydrate guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

What are the instructions for a missed or vomited dose of Vizimpro (dacomitinib monohydrate)?